AI-generated from publicly available materials.A groundbreaking technology from Leeds Teaching Hospitals NHS Trust, known as TANGO, is poised for global implementation following a commercial partnership with Epredia, a leading diagnostic glass slide manufacturer.
TANGO represents a significant advancement in pathology, facilitating the integration of digital pathology and AI into cancer diagnostics. Unlike traditional methods that rely on staining techniques, TANGO employs a unique reference slide designed to enhance quality control during the staining process. This innovation aims to minimize variability in results, ultimately supporting more accurate and efficient cancer diagnostics.
The partnership with Epredia is expected to broaden the availability of TANGO, allowing for its adoption across NHS facilities and internationally. This collaboration not only signifies a step forward for Leeds Teaching Hospitals but also positions the UK as a potential leader in health technology innovation. According to Professor David Brettle, the technology was developed to address challenges in pathology labs, and its global rollout could lead to quicker diagnostic results for patients.
The integration of TANGO into Epredia's product line, set to begin in late 2026, highlights the growing importance of digital pathology and AI in improving healthcare outcomes. As noted by local leaders, this initiative showcases the collaborative efforts of hospitals, universities, and businesses in driving technological advancements that enhance patient care and create skilled job opportunities in the region.